Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-3000-2026

American Contract System Convenience Kit, CV B PACK Recall

American Contract System Convenience Kit, CV B PACK, Model/Catalog Number: TNCB10AM

FDA recall Class II

Ongoing

FDA lists this Class II recall for American Contract System Convenience Kit, CV B PACK. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-3000-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Jun 29, 2026
FDA report date
Sep 2, 2026
Quantity in commerce
30 units
Distribution
See key details
FDA cause
Nonconforming Material/Component

What is being recalled?

American Contract System Convenience Kit, CV B PACK, Model/Catalog Number: TNCB10AM

Affected model & UDI checker

Search the exact identifiers published for Z-3000-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
TNCB10AMAmerican Contract System Convenience Kit, CV B PACKCheck source noticeNot specified
Not specifiedAmerican Contract System Convenience Kit, CV B PACKCheck source notice191072232991
FDA code information

Lot Code: Lot Number: 42-8493811 UDI: 191072232991 Expiration Date: 7/15/2026

View the original FDA recall notice

Why was this product recalled?

The Convenience Kits contain Medline s Red Rubber Intermittent Catheters (8Fr-22 Fr) and Red Rubber Intermittent Catheter Trays. Medline Industries, LP has identified representative samples did not meet applicable performance specifications.

What actions did AMERICAN CONTRACT SYSTEMS, INC. take?

An URGENT: MEDICAL DEVICE RECALL NOTIFICATION letter dated 6/29/26 was sent to customers. ACTIONS TO TAKE: "Identify, segregate, and quarantine all impacted product. Other components within the convenience kits can still be used once kit is properly labeled with the warning label below. "Add warning labels to affected ACS kits to ensure all users are aware of the actions below and identified in the enclosed Medline recall notice. A labeling template is enclosed for printing labels which can be affixed on all affected kits and cases in inventory. Please contact your Sales Representative if pre-printed labels are needed. This label should be applied in a prominently visible location to end-users. The location chosen should not cover any other critical product information found on existing product labeling. "Customers (end-users): If you received product from a distributor, please contact the distributor or your sales representative with any questions you may have, or to request printed labels. "Distributors: If any of the affected kits identified above were further distributed, please ensure all end-users are appropriately notified and maintain records of effectiveness. "Complete the attached Recall Response Form and return by July 17, 2026. Report any quality problems or adverse events associated with the products listed in this notification to complaints@owens-minor.com . Your assistance is appreciated and necessary to prevent any risk to patient or medical professional health as a result of not following these instructions.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology